Category: Healthcare Sector
The analysis published under this category are as follows.Wednesday, September 12, 2012
Forget Osteoarthritis, Medical Breakthrough Promises the End the Pain / Companies / Healthcare Sector
Michael A. Robinson writes: A team of researchers at Harvard University just reported a fantastic new medical breakthrough - in the form of a hydrogel.
The compound is made mostly of water, but it's almost unbelievably tough, strong, and resilient. It can stretch to more than 20 times its original length.
Read full article... Read full article...
Friday, September 07, 2012
Post-Obamacare Healthcare Sector Investor Opportunities / Companies / Healthcare Sector
New product visibility is vital in medical device stories. Without something new to show physicians, there is no way to get through the door. Medical Devices and Outsourcing Services Analyst James Terwilliger of The Benchmark Company looks for investments that will pique the interests of cardiologists, orthopedists and long-term care facilities. In this exclusive interview with The Life Sciences Report, Terwilliger shares the names of companies poised to grow as the economy rebounds over the next two years.
Read full article... Read full article...
Wednesday, August 08, 2012
Steve Austin Lives, Our Bionic Future Has Arrived / Companies / Healthcare Sector
Michael A. Robinson writes: Get ready for bionic humans.
They'll be faster, stronger, and much smarter than we are today. They'll wear exoskeletons made of smart materials, complete with onboard computing.
Part of their enhanced IQs may come from implants in their eyes that automatically access the wireless Web.
Read full article... Read full article...
Sunday, July 29, 2012
Doctors Are Like Cops, Dangerous / Politics / Healthcare Sector
Jack D. Douglas writes: This is a good study of the soaring rate of dangerous MRSA infection from hospital stays by academic hospital insiders who used their inside knowledge of the U. of Chicago hospital and three others to correct for the massive 30% to 50% official underreporting and found that one out of twenty plus patients now gets serious MRSA hospital infection in the U.S., more than all the influenza and AIDS hospitalizations combined. That was a 100% increase in five years and the study ended in '08, so there has probably been another near doubling, or less if the growing infection control efforts coming out of Hopkins, etc., are beginning to pay off.
Read full article... Read full article...
Friday, July 20, 2012
Healthcare Stocks: Mergers Show How Obamacare Will Deliver Investor Profits / Companies / Healthcare Sector
Don Miller writes: Want proof that healthcare stocks are poised to reap rewards from Obamacare?
Just take a look at this recent blockbuster healthcare merger.
Giant managed care firm WellPoint Inc. (NYSE: WLP) announced July 9 that it would buy Amerigroup Corp. (NYSE: AGP), the country's largest private Medicaid managed care company, for $4.9 billion in cash.
Read full article... Read full article...
Thursday, July 19, 2012
Why Your Health Care Is so Darn Expensive... / Politics / Healthcare Sector
Alex Daley and Doug Hornig,Senior Editors, Casey Extraordinary Technology
The cellphone in your pocket is NASA-smart. Yet it costs just a couple hundred dollars.
So why is it that rising technical capabilities are leading to drastically falling prices happening everywhere, except in your medical bill?
The answer may surprise you…
Thursday, July 19, 2012
Boots Opticians Having Problems Digesting D&A? Discount Voucher and Review / ConsumerWatch / Healthcare Sector
Following my recent vision problem for some 15 minutes whilst at Manchester Airport, I had no choice but to bite the bullet and visit my local GP (ecclesall medical centre). Whilst my expectations were already low, they still managed to disappoint, seems like the reception staff are trained to so their best to obstruct patients, but that's for another article, the long and short of it was I had to go and see an optician (at my own expense) with a scrap of paper from the Doc to determine if there was a problem with my eyes or not.
Read full article... Read full article...
Sunday, July 15, 2012
It's Not Too Late to Buy into the Pharma Stock Powerful Uptrend / Companies / Healthcare Sector
Brett Eversole writes: Drug stocks have been on a tear this year.
Pharmaceutical giant Abbott Labs is up 18%. Smaller names like Questcor and Auxilium are up 38% and 35%, respectively.
The sector overall – as measured by the PowerShares Dynamic Pharmaceuticals fund (PJP) – is up 19% so far in 2012... more than double the S&P 500's 9% return.
Friday, June 29, 2012
Don't Expect the Obamacare Ruling to Calm the Markets / Politics / Healthcare Sector
Shah Gilani writes: Even before the Supreme Court decision on Obamacare was handed down yesterday the markets were selling off hard.
They were tanking on news that the latest European summit was unlikely to be a game-changer, that U.S. gross domestic product was a paltry 1.9% in the first quarter, and a New York Times story that JPMorgan Chase's derivatives loss could top $9 billion.
Read full article... Read full article...
Thursday, June 14, 2012
Healthcare Stocks: What Happens if Obamacare is Overturned / Companies / Healthcare Sector
David Zeiler writes: With the Supreme Court ruling on President Barack Obama's healthcare reform law just three weeks away, investors in healthcare stocks need to be prepared.
While some are confident the Supreme Court will rule in favor of the Patient Protection and Affordable Care Act, a rejection of the law -- or at least of the mandate requiring everyone to buy insurance -- may be more likely.
Read full article... Read full article...
Tuesday, May 29, 2012
The 152-Year-Old Brain That Changed the Course of Science / Companies / Healthcare Sector
Michael Robinson writes: The most infamous man in the complex field of neuroscience died 152 years ago.
Yet just last week, railroad construction foreman Phineas Gage made headlines again, reaching out from the grave to offer crucial new insights about the how the brain works.
Read full article... Read full article...
Thursday, May 03, 2012
Experimental Brain Injury Treatments Could Be Worth Billions / Companies / Healthcare Sector
Michael A. Robinson writes: Brain trauma is one tough and expensive field.
Each year brain injuries cost the nation roughly $50 billion. That's half a trillion every decade.
Read full article... Read full article...
Friday, April 13, 2012
Vaccine Therapies Hold Promise for Investors / Companies / Healthcare Sector
Developing vaccines to treat and/or prevent disease promises life-changing benefits for patients and unique opportunities for investors. In this interview with The Life Sciences Report, LifeTech Capital Senior Managing Director and President Stephen Dunn discusses the roadblocks encountered by some developers of immune therapies and how other companies are working around those obstacles, producing investment opportunities in the process.
Read full article... Read full article...
Tuesday, April 10, 2012
Weight Loss Stocks Race to End the Obesity Epidemic With New Pills and Treatments / Companies / Healthcare Sector
DIANE ALTER writes: Obesity is considered the most serious health issue in the developed world. Along with growing waistlines also comes ballooning costs.
Across urbanized nations, the economic burden of obesity is estimated to be 10% of total health care costs, with projections continuing to grow as the obesity epidemic spreads.
Read full article... Read full article...
Monday, April 02, 2012
With or Without "Obamacare" These Healthcare Stocks Are Headed Higher / Companies / Healthcare Sector
Don Miller writes: The fat lady hasn't sung yet...but she is warming up.
Three days of arguments before the Supreme Court have made it abundantly clear - "Obamacare" is in danger of being gutted or completely wiped off the books.
Read full article... Read full article...
Thursday, March 01, 2012
Investing in Microchip Medicine Tha Will Save Millions of Lives / Companies / Healthcare Sector
Michael Robinson writes: A new generation of medical devices is set to have a profound impact on American health - and wealth.
You see, I know from detailed research and analysis that more than 100,000 people in the U.S. die each year from bad reactions to drugs.
Read full article... Read full article...
Sunday, August 07, 2011
The Economics of US Healthcare, a Giant Ponzi Scheme? / Economics / Healthcare Sector
Gilbert G. Berdine writes: According to the US Department of Health and Human Services (HHS), national health expenditures were $2.5 trillion in 2009, or $8,086 per person. The usual critique of US healthcare discusses how the money is spent and argues that it could be better spent in other ways.
I will not discuss how the money is spent, because value is subjective. Instead, I will show that the United States cannot afford what it spends, and, as a result, the US healthcare system is a credit-induced bubble.
Read full article... Read full article...
Friday, July 29, 2011
Fighting Cancer Ourselves / Companies / Healthcare Sector
Chris Wood, Casey Extraordinary Technology writes: Worldwide, tens of thousands of researchers are working feverishly on a cure for cancer, testing countless new drugs and dozens of novel approaches. Most will end up in the dustbin. But among the most promising of that small group likely to make it to market is a new type of monoclonal antibody therapy.
Read full article... Read full article...
Wednesday, July 27, 2011
Next Step: A Home Cancer Test Kit? / Stock-Markets / Healthcare Sector
Doug Hornig, Casey Extraordinary Technology writes: With cancer, early detection equals a greater likelihood that treatment will have a positive outcome.
Physicians have known this for a long time, and the statistics back them up. Survival rates for those afflicted with many types of cancer have risen dramatically in the past few decades. And one of the primary reasons is that we are diagnosing cancer earlier and with much greater accuracy.
Read full article... Read full article...
Thursday, July 07, 2011
How Antimicrobial Copper Could Save Thousands of Lives, Billions of Dollars / Stock-Markets / Healthcare Sector
David Zeiler writes: In less than two hours this material can kill 99.9% of most of the bacteria on its surface, including E.coli, influenza, staphylococcus and H1N1.
A recent four-year trial has shown that using it on such frequently touched hospital items as bed rails, IV poles, tray tables and nurse call buttons reduces infection rates by more than 40%.
Read full article... Read full article...